Neuropeptides
Volume 44, Issue 5 , Pages 407-411 , October 2010

Vasoactive intestinal peptide induces vascular endothelial growth factor production in human HaCaT keratinocytes via MAPK pathway

  • Xiao-Jing Yu

      Affiliations

    • Department of Dermatology, Qilu Hospital, University of Shandong, Jinan 250012, China
    • ,
  • Xiao-Hong Ren

      Affiliations

    • Department of Dermatology, The Central Hospital of Taian, Shandong Province, Taian 271000, China
    • ,
  • Yong-Hao Xu

      Affiliations

    • Department of Dermatology, Qilu Hospital, University of Shandong, Jinan 250012, China
    • ,
  • La-Mei Chen

      Affiliations

    • Department of Dermatology, Qilu Hospital, University of Shandong, Jinan 250012, China
    • ,
  • Chun-Lei Zhou

      Affiliations

    • Department of Dermatology, Qilu Hospital, University of Shandong, Jinan 250012, China
    • ,
  • Chun-Yang Li

      Affiliations

    • Department of Dermatology, Qilu Hospital, University of Shandong, Jinan 250012, China
    • Corresponding Author InformationCorresponding author. Tel.: +86 531 82169390; fax: +86 531 86927544.

Received 20 December 2009 ,Accepted 7 May 2010.

References 

  1. Baker BS, Fry L. The immunology of psoriasis. Br. J. Dermatol. 1992;126:1–9
  2. Bonnekoh B, Wevers A, Geisel J, Rasokat H, Mahrle G. Antiproliferative potential of zidovudine in human keratinocyte cultures. J. Am. Acad. Dermatol. 1991;25:483–490
  3. Collado B, Carmena MJ, Clemente C, Prieto JC, Bajo AM. Vasoactive intestinal peptide enhances growth and angiogenesis of human experimental prostate cancer in a xenograft model. Peptides. 2007;28:1896–1901
  4. Collado B, Gutiérrez-Cañas I, Rodríguez-Henche N, Prieto JC, Carmena MJ. Vasoactive intestinal peptide increases vascular endothelial growth factor expression and neuroendocrine differentiation in human prostate cancer LNCaP cells. Regul. Pept. 2004;119:69–75
  5. Collado B, Sánchez-Chapado M, Prieto JC, Carmena MJ. Hypoxia regulation of expression and angiogenic effects of vasoactive intestinal peptide (VIP) and VIP receptors in LNCaP prostate cancer cells. Mol. Cell. Endocrinol. 2006;25(249):116–122
  6. Creamer D, Allen MH, Sousa A, Poston R, Barker JN. Localization of endothelial proliferation and microvascular expansion in active plaque psoriasis. Br. J. Dermatol. 1997;136:859–865
  7. Dallos A, Kiss M, Polyánka H, Dobozy A, Kemény L, Husz S. Effects of the neuropeptides substance P, calcitonin gene-related peptide, vasoactive intestinal polypeptide and galanin on the production of nerve growth factor and inflammatory cytokines in cultured human keratinocytes. Neuropeptides. 2006;251–263
  8. Detmar M, Brown LF, Claffey KP, Yeo KT, Kocher O, Jackman RW, et al. Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J. Exp. Med. 1994;180:1141–1146
  9. Detmar M, Brown LF, Schon MP, Elicker BM, Velasco P, Richard L, et al. Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. J. Invest. Dermatol. 1998;111:1–6
  10. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr. Rev. 1997;18:4–25
  11. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1995;1:27–31
  12. Geilen CC, Bektas M, Wieder T, Kodelja V, Goerdt S, Orfanos CE. 1alpha, 25-dihydroxyvitamin D3 induces sphingomyelin hydrolysis in HaCaT cells via tumor necrosis factor alpha. J. Biol. Chem. 1997;272:8997–9001
  13. Granoth R, Fridkin M, Gozes I. VIP and the potent analog, stearyl-Nle(17)-VIP, induce proliferation of keratinocytes. FEBS Lett. 2000;475:78–83
  14. Johansen C, Kragballe K, Westergaard M, Henningsen J, Kristiansen K, Iversen L. The mitogen-activated protein kinases p38 and ERK1/2 are increased in lesional psoriatic skin. Br. J. Dermatol. 2005;152:37–42
  15. Kakurai M, Demitsu T, Umemoto N, Kobayashi Y, Inoue-Narita T, Fujita N, et al. Vasoactive intestinal peptide and inflammatory cytokines enhance vascular endothelial growth factor production from epidermal keratinocytes. Br. J. Dermatol. 2009;161:1232–1238
  16. Mattei MG, Borg JP, Rosnet O, Marme D, Birnbaum D. Assignment of vascular endothelial growth factor (VEGF) and placenta growth factor (PLGF) genes to human chromosome 6p12–p21 and 14q24–q31 regions, respectively. Genomics. 1996;3:168–169
  17. Muller K, Prinz H. Antipsoriatic anthrones with modulated redox properties. 4. Synthesis and biological activity of novel 9,10-dihydro-1,8-dihydroxy-9-oxo-2-anthracenecarboxylic and -hydroxamic acids. J. Med. Chem. 1997;40:2780–2787
  18. Nair RP, Stuart P, Henseler T, Jenisch S, Chia NV, Westphal E, et al. Localization of psoriasis-susceptibility locus PSORS1 to a 60-kb interval telomeric to HLA-C. Am. J. Hum. Genet. 2000;66:1833–1844
  19. Park YM, Kim CW. The effects of substance P and vasoactive intestinal peptide on interleukin-6 synthesis in cultured human keratinocytes. J. Dermatol. Sci. 1999;22:17–23
  20. Pincelli C, Fantini F, Romualdi P, Cinzia S, Lesa G, Benassi L, et al. Substance P is diminished and vasoactive intestinal peptide is augmented in psoriatic lesions and these peptides exert disparate effects on the proliferation of cultured keratinocytes. J. Invest. Dermatol. 1992;98:421–427
  21. Sung KJ, Chang SE, Paik EM, Lee MW, Choi JH. Vasoactive intestinal polypeptide stimulates the proliferation of HaCaT cell via TGF-alpha. Neuropeptides. 1999;33:435–446
  22. Toumi F, Neunlist M, Denis MG, Oreshkova T, Laboisse CL, Galmiche JP, et al. Vasoactive intestinal peptide induces IL-8 production in human colonic epithelial cells via MAP kinase-dependent and PKA-independent pathways. Biochem. Biophys. Res. Commun. 2004;317:187–191
  23. Trembath RC, Clough RL, Rosbotham JL, Jones AB, Camp RD, Frodsham A, et al. Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci revealed by a two stage genome-wide search in psoriasis. Hum. Mol. Genet. 1997;6:813–820
  24. Valdehita A, Carmena MJ, Collado B, Prieto JC, Bajo AM. Vasoactive intestinal peptide (VIP) increases vascular endothelial growth factor (VEGF) expression and secretion in human breast cancer cells. Regul. Pept. 2007;144:101–108
  25. Vincenti V, Cassano C, Rocchi M, Persico G. Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3. Circulation. 1996;93:1493–1495
  26. Voice JK, Dorsam G, Chan RC, Grinninger C, Kong Y, Goetzl EJ. Immunoeffector and immunoregulatory activities of vasoactive intestinal peptide. Regul. Pept. 2002;109:199–208
  27. Wraight CJ, Werther GA. Insulin-like growth factor-I and epidermal growth factor regulate insulin-like growth factor binding protein-3 (IGFBP-3) in the human keratinocyte cell line HaCaT. J. Invest. Dermatol. 1995;105:602–607
  28. Xia YP, Li B, Hylton D, Detmar M, Yancopoulos GD, Rudge JS. Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis. Blood. 2003;102:161–168
  29. Yu XJ, Li CY, Dai HY, Cai DX, Wang KY, Xu YH, et al. Expression and localization of the activated mitogen-activated protein kinase in lesional psoriatic skin. Exp. Mol. Pathol. 2007;83:413–418

PII: S0143-4179(10)00051-X

doi: 10.1016/j.npep.2010.05.002

Neuropeptides
Volume 44, Issue 5 , Pages 407-411 , October 2010

Article Tools

* Image Usage & Resolution